Rajiv Shah Net Worth

Rajiv Shah biography

Dr. Rajiv Shah M.D. serves as Independent Director of the Company. Dr. Shah has served on our board of directors since June 2015 and on our scientific committee since September 2019. Dr. Shah has served as the president of the Rockefeller Foundation since February 2017. From March 2015 to February 2017, Dr. Shah was the managing partner of Latitude Capital, an emerging markets private equity firm that he founded. Dr. Shah served as administrator of the United States Agency for International Development, or USAID, from January 2010 to February 2015. Dr. Shah served as undersecretary and chief scientist at the U.S. Department of Agriculture from May 2009 to January 2010, during which time he created the National Institute for Food and Agriculture. Prior to working in government, Dr. Shah worked in senior roles at the Bill & Melinda Gates Foundation, leading the Foundation’s efforts in global health, agriculture and financial services. Dr. Shah also serves on the board of trustees of the Rockefeller Foundation and is a distinguished fellow in residence at Georgetown University, Edmund A. Walsh School of Foreign Service. From March 2015 to June 2017, Dr. Shah served on the board of directors of Arcadia Biosciences, Inc., a publicly traded agricultural technology company. Dr. Shah earned his M.D. from the University of Pennsylvania Medical School, his M.S. in Health Economics at the Wharton School of Business and his B.S. in Economics from the University of Michigan. Our nominating and governance committee has concluded that Dr. Shah should continue to serve on the board of directors based on his experience in government, regulatory affairs, international development and strategic partnerships, as well as his scientific background.

What is the salary of Rajiv Shah?

As the Independent Director of Omeros, the total compensation of Rajiv Shah at Omeros is $125,170. There are 12 executives at Omeros getting paid more, with Gregory Demopulos having the highest compensation of $4,825,130.

How old is Rajiv Shah?

Rajiv Shah is 47, he's been the Independent Director of Omeros since 2015. There are 28 older and 2 younger executives at Omeros. The oldest executive at Omeros Corporation is Ray Aspiri, 83, who is the Independent Director.

What's Rajiv Shah's mailing address?

Rajiv's mailing address filed with the SEC is 201 ELLIOTT AVENUE WEST, , SEATTLE, WA, 98119.

Insiders trading at Omeros

Over the last 15 years, insiders at Omeros have traded over $719,810 worth of Omeros stock and bought 141,095 units worth $829,835 . The most active insiders traders include Gregory A Md Demopulos, Marcia S. Kelbon e Daniel K Spiegelman. On average, Omeros executives and independent directors trade stock every 53 days with the average trade being worth of $97,792. The most recent stock trade was executed by Gregory A Md Demopulos on 17 November 2023, trading 15,000 units of OMER stock currently worth $25,200.

What does Omeros do?

omeros is a seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system.

Omeros executives and stock owners

Omeros executives and other stock owners filed with the SEC include:

• Gregory Demopulos,
  Chairman of the Board, President, Chief Executive Officer
• Dr. Gregory A. Demopulos,
  Co-Founder, Chairman, CEO & Pres
• Dr. Gregory A. Demopulos M.D.,
  Co-Founder, Chairman, CEO & Pres
• Michael Jacobsen,
  Chief Accounting Officer, Vice President - Finance, Treasurer
• Peter Cancelmo,
  Vice President, General Counsel, Secretary
• Michael A. Jacobsen,
  Chief Accounting Officer, VP of Fin. & Treasurer
• Peter B. Cancelmo J.D.,
  VP, Gen. Counsel & Corp. Sec.
• Thomas Bumol,
  Independent Director
• Thomas Cable,
  Lead Independent Director
• Ray Aspiri,
  Independent Director
• Arnold Hanish,
  Independent Director
• Leroy Hood,
  Independent Director
• Rajiv Shah,
  Independent Director
• Peter Demopulos,
  Director
• Kurt Zumwalt,
  Independent Director
• Timothy Duffy,
  Vice President - Business Development
• J. Steven Whitaker,
  Vice President, Chief Medical Officer
• Tina Quinton,
  Vice President - Patents
• Catherine Melfi,
  Vice President - Regulatory Affairs & Quality Systems, Chief Regulatory Officer
• Bruce Meiklejohn,
  Vice President - Chemistry, Manufacturing and Controls
• Daniel Kirby,
  Vice President, Chief Commercial Officer
• Christopher Bral,
  Vice President - Nonclinical Development
• George Gaitanaris,
  Chief Scientific Officer, Vice President - Science
• Dr. J. Steven Whitaker J.D., M.D.,
  VP of Clinical Devel. & Chief Medical Officer
• Dr. Pamela Pierce Palmer M.D., Ph.D.,
  Co-Founder
• Nadia Dac,
  Chief Commercial Officer
• Dr. Catherine A. Melfi,
  Chief Regulatory Officer & VP of Regulatory Affairs and Quality Systems
• Dr. J. Steven Whitaker,
  VP of Clinical Devel. & Chief Medical Officer
• Peter W. Williams,
  VP of HR
• Dr. George A. Gaitanaris M.D., Ph.D.,
  Chief Scientific Officer & VP of Science
• Dr. Pamela Pierce Palmer,
  Co-Founder
• Marcia S. Kelbon,
  VP Patent and General Counsel
• Diana T. Perkinson,
  Director
• Daniel K Spiegelman,
  Director
• Jean Philippe Tripet,
  Director